PT944611E - Sais dimesilato de ligandos de neuropeptideo y - Google Patents

Sais dimesilato de ligandos de neuropeptideo y

Info

Publication number
PT944611E
PT944611E PT97910602T PT97910602T PT944611E PT 944611 E PT944611 E PT 944611E PT 97910602 T PT97910602 T PT 97910602T PT 97910602 T PT97910602 T PT 97910602T PT 944611 E PT944611 E PT 944611E
Authority
PT
Portugal
Prior art keywords
neuropeptideo
ligands
dimesylate
salts
dimesylate salts
Prior art date
Application number
PT97910602T
Other languages
English (en)
Portuguese (pt)
Inventor
Douglas J M Allen
Lyle R Brostrom
Alireza S Kord
Laurie A Whipple
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT944611E publication Critical patent/PT944611E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT97910602T 1996-11-26 1997-11-19 Sais dimesilato de ligandos de neuropeptideo y PT944611E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3181596P 1996-11-26 1996-11-26

Publications (1)

Publication Number Publication Date
PT944611E true PT944611E (pt) 2004-04-30

Family

ID=21861551

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97910602T PT944611E (pt) 1996-11-26 1997-11-19 Sais dimesilato de ligandos de neuropeptideo y

Country Status (23)

Country Link
US (1) US5914329A (enExample)
EP (1) EP0944611B1 (enExample)
JP (1) JP3120861B2 (enExample)
AP (1) AP9701148A0 (enExample)
AR (1) AR010304A1 (enExample)
AT (1) ATE257472T1 (enExample)
AU (1) AU4792497A (enExample)
BR (1) BR9713538A (enExample)
CA (1) CA2272927C (enExample)
DE (1) DE69727155T2 (enExample)
DK (1) DK0944611T3 (enExample)
ES (1) ES2213207T3 (enExample)
GT (1) GT199700123A (enExample)
HN (1) HN1997000154A (enExample)
HR (1) HRP970640A2 (enExample)
ID (1) ID18964A (enExample)
MA (1) MA26450A1 (enExample)
PA (1) PA8441701A1 (enExample)
PE (1) PE17099A1 (enExample)
PT (1) PT944611E (enExample)
TN (1) TNSN97191A1 (enExample)
WO (1) WO1998023603A1 (enExample)
ZA (1) ZA9710587B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001232900A1 (en) * 2000-01-20 2001-07-31 Michael Amling Methods and compositions for control of bone formation via modulation of neuropeptide y activity
JP2005516001A (ja) 2001-12-05 2005-06-02 ベイラー カレッジ オブ メディスン 交感神経活動状態の調節による骨形成の制御のための方法及び組成物
NZ533848A (en) 2002-01-09 2006-11-30 Arexis Ab Detection of mutations in the flavin-containing monooxygenase (FMO3) gene
EP1701722B1 (en) * 2004-11-23 2009-10-14 Dong Wha Pharmaceutical Co., Ltd. N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy¨]pentoxy}benzamidine 2 methansulfonic acid salt
EP1877076A4 (en) * 2005-04-15 2012-02-01 Regenertech Pty Ltd USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK57097A3 (en) * 1994-11-07 1998-10-07 Pfizer Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands

Also Published As

Publication number Publication date
AP9701148A0 (en) 1998-01-31
ES2213207T3 (es) 2004-08-16
ATE257472T1 (de) 2004-01-15
AU4792497A (en) 1998-06-22
JP3120861B2 (ja) 2000-12-25
GT199700123A (es) 1999-05-19
JP2000505110A (ja) 2000-04-25
ID18964A (id) 1998-05-28
PA8441701A1 (es) 2000-05-24
CA2272927A1 (en) 1998-06-04
MA26450A1 (fr) 2004-12-20
DE69727155D1 (de) 2004-02-12
CA2272927C (en) 2003-02-04
PE17099A1 (es) 1999-02-19
DK0944611T3 (da) 2004-04-13
TNSN97191A1 (fr) 2005-03-15
US5914329A (en) 1999-06-22
DE69727155T2 (de) 2004-07-08
HRP970640A2 (en) 1998-10-31
BR9713538A (enExample) 2000-03-21
HN1997000154A (es) 1999-02-09
ZA9710587B (en) 1999-05-25
AR010304A1 (es) 2000-06-07
EP0944611B1 (en) 2004-01-07
WO1998023603A1 (en) 1998-06-04
EP0944611A1 (en) 1999-09-29

Similar Documents

Publication Publication Date Title
ATE261935T1 (de) Neue metformin salze und verfahren
PT900088E (pt) Complexos de inclusao de sais aril-heterociclicos
DE69834401D1 (de) Businterfacesystem und verfahren
DE19580279T1 (de) Schlüsselanhänger- und Befestigung
BR9709811A (pt) Composto de indenonaftopiranos e artigo fotocrómico
BR9711799A (pt) Composto de indenonaftopiranos e artigo fotocr-mico
FI965145L (fi) Suodatus
PT904095E (pt) Isoprenoide-sintases quimericas e suas utilizacoes
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
NO992104D0 (no) Isokinoloner
DE69528046D1 (de) Polychelate
FI981263A0 (fi) Suodatinapuprosessori
PT944611E (pt) Sais dimesilato de ligandos de neuropeptideo y
DE69526841D1 (de) Verfahren zur Wiedergabe
NO970431D0 (no) Tetrahydroisokinolin-derivater
KR980000948U (ko) 블록 놀이 기구
KR950023417U (ko) 수로용 법면블럭
FI100512B (fi) Lehtiötaulu
KR980002874U (ko) 자화수필터채용 정수기
BR9402163A (pt) Dessalinizador de água salgada e similares
ITMI940986A1 (it) Dipeptidi e pseudodipeptidi
KR960004116U (ko) 타력 놀이기구
KR960013436U (ko) 놀이기구
KR970058958U (ko) 배관용 클립
KR970060830U (ko) 놀이기구 및 운동용 삼륜차